Cameron John Reynolds - Mar 26, 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role
President and CEO, Director
Signature
/s/ Cameron John Reynolds
Stock symbol
VNRX
Transactions as of
Mar 26, 2025
Transactions value $
$100,000
Form type
4
Date filed
3/27/2025, 08:13 AM
Previous filing
Jan 31, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Purchase $100K +182K +8.59% $0.55 2.3M Mar 26, 2025 Direct F1
holding VNRX Common Stock 1.01M Mar 26, 2025 By Concord International, Inc. F2
holding VNRX Common Stock 34.1K Mar 26, 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx.
F2 The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.